This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
A Study to Assess the Efficacy and Safety of RO7965032 in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration | MicrobiomeTrials
← Back to trials NCT07851259
A Study to Assess the Efficacy and Safety of RO7965032 in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration Recruiting PHASE2 INTERVENTIONAL
Read the full scientific description See full eligibility requirements Trial Details Start: 2027-01-08Est. Completion: 2030-08-21
Enrollment target: 321 participantsLocations Bay Area Retina Specialists Medical Group - Vestrum - PPDS, Walnut Creek, California, United States Piedmont Retina Specialists, Winston-Salem, North Carolina, United States Erie Retina Research, Erie, Pennsylvania, United States Texas Retina Associates - Arlington, Arlington, Texas, United States Piedmont Eye Center, Lynchburg, Virginia, United States Other microbiome trials you might be interested in Geographic Atrophy
This research sub-study is to evaluate if combining images from Optical Coherence Tomography (OCT) scans with Adaptive O…
Madison, United States Completed Feb 2027
Geographic Atrophy of the Macula
Age-related macular degeneration (AMD) affects millions of elderly patients. When advanced, there is Geographic Atrophy …
Beverly Hills, United States Est. completion Mar 30, 2027
Fastest Response: use the inquiry form. https://www.gene.com/contact-us/submit-medical-inquiry